Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Brocks

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Therapeutic Drug Monitoring|January 1, 1988
A pharmacokinetic dosing method for oral theophylline in pediatric patientsD R Brocks, K C Lee, Y K Tam, et al.
The Journal of Prevention of Alzheimer'S Disease|December 18, 2020
Assessing the Impact of Factors that Influence the Ketogenic Response to Varying Doses of Medium Chain Triglyceride (MCT) OilA G Juby, D R Brocks, D A Jay, et al.
British Journal of Clinical Pharmacology|September 20, 1997
Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteersD R Brocks, J Upward, M Davy, et al.
Journal of Clinical Pharmacology|November 1, 1994
Hematologic disposition of hydroxychloroquine enantiomersD R Brocks, K J Skeith, C Johnston, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 1, 1996
The pharmacokinetics of pranlukast in healthy young and elderly subjectsD R Brocks, J Upward, R Hust, et al.
Diabetes, Obesity & Metabolism|September 20, 2011
Variations in tissue selectivity amongst insulin secretagogues: a systematic reviewA S Abdelmoneim, S E Hasenbank, J M Seubert, et al.
European Journal of Clinical Pharmacology|January 1, 1996
The single and multiple dose pharmacokinetics of pranlukast in healthy volunteersD R Brocks, J W Upward, P Georgiou, et al.
Journal of Clinical Pharmacology|August 1, 1996
Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: influence of doseD R Brocks, A W Meikle, S C Boike, et al.
Pharmaceutical Research|May 1, 1996
Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patientsD R Brocks, M I Freed, D E Martin, et al.
American Journal of Clinical Oncology|April 16, 1998
SK&F107647: a synthetic hematoregulatory peptide in patients with solid tumor malignancies: a phase I trialJ Nemunaitis, D E Martin, D L Willis, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Therapeutic Drug Monitoring|January 1, 1988
A pharmacokinetic dosing method for oral theophylline in pediatric patientsD R Brocks, K C Lee, Y K Tam, et al.
The Journal of Prevention of Alzheimer'S Disease|December 18, 2020
Assessing the Impact of Factors that Influence the Ketogenic Response to Varying Doses of Medium Chain Triglyceride (MCT) OilA G Juby, D R Brocks, D A Jay, et al.
British Journal of Clinical Pharmacology|September 20, 1997
Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteersD R Brocks, J Upward, M Davy, et al.
Journal of Clinical Pharmacology|November 1, 1994
Hematologic disposition of hydroxychloroquine enantiomersD R Brocks, K J Skeith, C Johnston, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 1, 1996
The pharmacokinetics of pranlukast in healthy young and elderly subjectsD R Brocks, J Upward, R Hust, et al.
Diabetes, Obesity & Metabolism|September 20, 2011
Variations in tissue selectivity amongst insulin secretagogues: a systematic reviewA S Abdelmoneim, S E Hasenbank, J M Seubert, et al.
European Journal of Clinical Pharmacology|January 1, 1996
The single and multiple dose pharmacokinetics of pranlukast in healthy volunteersD R Brocks, J W Upward, P Georgiou, et al.
Journal of Clinical Pharmacology|August 1, 1996
Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: influence of doseD R Brocks, A W Meikle, S C Boike, et al.
Pharmaceutical Research|May 1, 1996
Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patientsD R Brocks, M I Freed, D E Martin, et al.
American Journal of Clinical Oncology|April 16, 1998
SK&F107647: a synthetic hematoregulatory peptide in patients with solid tumor malignancies: a phase I trialJ Nemunaitis, D E Martin, D L Willis, et al.
Pageof 4